Dabigatran emerges as safe and effective warfarin alternative. The recently approved drug is more expensive, but appears to be more predictable

Heart Advis. 2011 Jan;14(1):4.
No abstract available

MeSH terms

  • Anticoagulants / economics
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / economics
  • Benzimidazoles / therapeutic use*
  • Dabigatran
  • Drug Approval
  • Drug Interactions
  • Humans
  • Stroke / prevention & control*
  • United States
  • United States Food and Drug Administration
  • Venous Thromboembolism / prevention & control*
  • Warfarin / economics
  • Warfarin / therapeutic use
  • beta-Alanine / analogs & derivatives*
  • beta-Alanine / economics
  • beta-Alanine / therapeutic use

Substances

  • Anticoagulants
  • Benzimidazoles
  • beta-Alanine
  • Warfarin
  • Dabigatran